Weight-loss drug to be pulled from market after FDA expresses concerns on cancer risk
The Japanese drug maker Eisai said it would withdraw the weight-loss drug Belviq from the U.S. market after the FDA expressed concerns about an increased occurrence of cancer reported in…
by Adam Feuerstein
Feb 13, 2020
1 minute
The Japanese drug maker Eisai on Thursday said it would withdraw the weight-loss drug Belviq from the U.S. market after the Food and Drug Administration expressed concerns about an increased occurrence of cancer reported in people who used the
You’re reading a preview, subscribe to read more.
Start your free 30 days